FIELD: medicine.
SUBSTANCE: what is presented is a Bacillus subtilis 804 strain produced from a patient's unremarkable wound. The Bacillus subtilis 804 strain is deposited in the State collection of pathogenic microorganisms III-IV of L.A. Tarasevich State Research Institution of Standardisation and Control of Medical Biological Preparations, No. 288 and is a fibroblast growth factor producer in an environment.
EFFECT: preparations of the produced bacterial factor accelerate skin and mucosa wound healing.
Authors
Dates
2011-08-27—Published
2010-06-28—Filed